Immunomedics Inc
IMMU
IMMU was delisted on the 22nd of October, 2020.
245 hedge funds and large institutions have $3.65B invested in Immunomedics Inc in 2019 Q4 according to their latest regulatory filings, with 64 funds opening new positions, 82 increasing their positions, 64 reducing their positions, and 24 closing their positions.
167% more first-time investments, than exits
New positions opened: 64 | Existing positions closed: 24
116% more call options, than puts
Call options by funds: $91.3M | Put options by funds: $42.3M
70% more capital invested
Capital invested by funds: $2.15B → $3.65B (+$1.51B)
28% more repeat investments, than reductions
Existing positions increased: 82 | Existing positions reduced: 64
20% more funds holding in top 10
Funds holding in top 10: 5 → 6 (+1)
18% more funds holding
Funds holding: 208 → 245 (+37)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACA
Avoro Capital Advisors
New York
|
+$61.7M |
| 2 |
Ameriprise
Minneapolis,
Minnesota
|
+$36.1M |
| 3 |
Victory Capital Management
San Antonio,
Texas
|
+$28M |
| 4 |
BC
Boxer Capital
San Diego,
California
|
+$26.5M |
| 5 |
PHS
PFM Health Sciences
San Francisco,
California
|
+$26.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$42.3M |
| 2 |
DM
Deerfield Management
New York
|
-$26.3M |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$22.6M |
| 4 |
MMH
Menora Mivtachim Holdings
Ramat Gan,
Israel
|
-$19M |
| 5 |
TCM
TimesSquare Capital Management
New York
|
-$11.8M |
IMMU Hedge Fund Activity: Q4 2019 in Review
245 of the 5,076 institutional investors tracked by Wall St. Rank reported a position in Immunomedics Inc (IMMU) for Q4 2019, worth a combined $3.65B — up 70% from $2.15B a quarter earlier.
Buyers outnumbered sellers: 64 funds opened new IMMU positions and 24 closed out — a net gain of 40 holders — while 82 added to existing stakes and 64 trimmed.
The largest buyer was Avoro Capital Advisors, adding an estimated $61.7M. The largest seller was Fidelity Investments, cutting an estimated $42.3M.
- 245 institutional investors held Immunomedics Inc (IMMU) as of Q4 2019, up from 208 in Q3 2019.
- Funds reported $3.65B of Immunomedics Inc stock for Q4 2019, up 70% quarter-over-quarter.
- 64 funds opened new Immunomedics Inc positions in Q4 2019 and 24 closed out, a net change of +40 holders.
- The largest Immunomedics Inc buyer in Q4 2019 was Avoro Capital Advisors, an estimated $61.7M added.
- The largest Immunomedics Inc seller in Q4 2019 was Fidelity Investments, an estimated $42.3M sold.
Based on aggregated 13F filings for Q4 2019.